Enterprise Value
115.7M
Cash
66.2M
Avg Qtr Burn
-10.27M
Short % of Float
1.29%
Insider Ownership
4.42%
Institutional Own.
29.63%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CUE-101 (IL-2) Details Head and neck cancer, Head and neck squamous cell carcinoma, Cancer, Solid tumor/s, Human papillomavirus | Phase 1 Data readout | |
CUE-102 Details Wilms' Tumor 1 (WT1) | Phase 1 Data readout |